The role of vasodilator therapy in the treatment of severe chronic heart failure.

Abstract

The rationale for the use of vasodilating agents in the treatment of congestive heart failure is to reverse the systemic vasoconstriction that characterises patients with this disorder, and which may further limit cardiac performance. Nitrates were the first vasodilators used, followed by arterial vasodilators (hydralazine, minoxidil), alpha-adrenergic… (More)

Topics

Cite this paper

@article{Packer1986TheRO, title={The role of vasodilator therapy in the treatment of severe chronic heart failure.}, author={Mary Packer}, journal={Drugs}, year={1986}, volume={32 Suppl 5}, pages={13-26} }